FRG Family Wealth Advisors’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.39M | Sell |
20,079
-1,380
| -6% | -$236K | 0.56% | 44 |
|
|
2025
Q4 | $3.62M | Sell |
21,459
-3,338
| -13% | -$542K | 0.56% | 43 |
|
|
2025
Q3 | $3.58M | Sell |
24,797
-9,574
| -28% | -$1.31M | 0.58% | 43 |
|
|
2025
Q2 | $4.35M | Hold |
34,371
| – | – | 0.76% | 30 |
|
|
2025
Q1 | $4.4M | Sell |
34,371
-2,384
| -6% | -$323K | 0.85% | 30 |
|
|
2024
Q4 | $4.86M | Sell |
36,755
-140
| -0.4% | -$19.7K | 0.88% | 29 |
|
|
2024
Q3 | $5.37M | Sell |
36,895
-200
| -0.5% | -$28.9K | 0.96% | 27 |
|
|
2024
Q2 | $5.22M | Sell |
37,095
-510
| -1% | -$68.1K | 1.01% | 26 |
|
|
2024
Q1 | $4.77M | Sell |
37,605
-375
| -1% | -$51.2K | 0.94% | 28 |
|
|
2023
Q4 | $5.16M | Sell |
37,980
-1,015
| -3% | -$124K | 1.05% | 25 |
|
|
2023
Q3 | $4.77M | Sell |
38,995
-375
| -1% | -$47.7K | 1.08% | 25 |
|
|
2023
Q2 | $5M | Sell |
39,370
-1,317
| -3% | -$171K | 1.09% | 25 |
|
|
2023
Q1 | $5.26M | Hold |
40,687
| – | – | 1.2% | 25 |
|
|
2022
Q4 | $5.34M | Sell |
40,687
-7,516
| -16% | -$971K | 1.27% | 25 |
|
|
2022
Q3 | $5.64M | Sell |
48,203
-285
| -0.6% | -$35.4K | 1.39% | 22 |
|
|
2022
Q2 | $5.7M | Sell |
48,488
-170
| -0.3% | -$20.2K | 1.32% | 24 |
|
|
2022
Q1 | $6.34M | Sell |
48,658
-1,790
| -4% | -$233K | 1.23% | 23 |
|
|
2021
Q4 | $7.7M | Sell |
50,448
-5,992
| -11% | -$928K | 1.44% | 20 |
|
|
2021
Q3 | $9.13M | Sell |
56,440
-1,917
| -3% | -$323K | 1.79% | 13 |
|
|
2021
Q2 | $9.55M | Buy |
58,357
+1,020
| +2% | +$157K | 1.81% | 13 |
|
|
2021
Q1 | $8.63M | Buy |
57,337
+2,305
| +4% | +$366K | 1.76% | 14 |
|
|
2020
Q4 | $8.34M | Buy |
55,032
+6,337
| +13% | +$906K | 1.82% | 13 |
|
|
2020
Q3 | $6.59M | Sell |
48,695
-140
| -0.3% | -$19K | 1.6% | 16 |
|
|
2020
Q2 | $6.67M | Sell |
48,835
-447
| -0.9% | -$57K | 1.76% | 14 |
|
|
2020
Q1 | $5.31M | Sell |
49,282
-405
| -0.8% | -$46.6K | 1.61% | 17 |
|
|
2019
Q4 | $5.99M | Sell |
49,687
-3,110
| -6% | -$347K | 1.45% | 19 |
|
|
2019
Q3 | $5.25M | Buy |
52,797
+1,590
| +3% | +$166K | 1.36% | 24 |
|
|
2019
Q2 | $5.59M | Buy |
51,207
+6,192
| +14% | +$659K | 1.47% | 16 |
|
|
2019
Q1 | $5.03M | Buy |
45,015
+2,665
| +6% | +$292K | 1.43% | 16 |
|
|
2018
Q4 | $4.08M | Sell |
42,350
-2,630
| -6% | -$279K | 1.34% | 21 |
|
|
2018
Q3 | $5.49M | Buy |
44,980
+5,369
| +14% | +$632K | 1.5% | 15 |
|
|
2018
Q2 | $4.35M | Buy |
39,611
+8,285
| +26% | +$886K | 1.3% | 19 |
|
|
2018
Q1 | $3.34M | Buy |
31,326
+5,825
| +23% | +$646K | 1.11% | 20 |
|
|
2017
Q4 | $2.72M | Buy |
25,501
+10,474
| +70% | +$1.12M | 0.88% | 41 |
|
|
2017
Q3 | $1.67M | Buy |
15,027
+6,441
| +75% | +$688K | 0.58% | 58 |
|
|
2017
Q2 | $887K | Buy |
+8,586
| New | +$846K | 0.33% | 80 |
|
Other funds holding IBB
CB
FRG Family Wealth Advisors's IBB Position: Q1 2026 in Review
FRG Family Wealth Advisors reduced its iShares Biotechnology ETF (IBB) stake by 6.4% in Q1 2026, selling an estimated $236K and leaving 20,079 shares worth $3.39M. The position accounts for 0.56% of the portfolio, ranked #44.
FRG Family Wealth Advisors first reported a position in IBB in Q2 2017 and has held it in 36 quarters since. The position peaked at $9.55M in Q2 2021. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.
- FRG Family Wealth Advisors held 20,079 shares of iShares Biotechnology ETF worth $3.39M as of Q1 2026.
- FRG Family Wealth Advisors sold 1,380 iShares Biotechnology ETF shares in Q1 2026, an estimated $236K.
- iShares Biotechnology ETF made up 0.56% of FRG Family Wealth Advisors's portfolio in Q1 2026, its #44 holding.
- FRG Family Wealth Advisors first reported a position in iShares Biotechnology ETF in Q2 2017 and has held it in 36 quarters since.
- FRG Family Wealth Advisors's iShares Biotechnology ETF position peaked at $9.55M in Q2 2021.
- 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.
Based on FRG Family Wealth Advisors's 13F filing for Q1 2026, filed 24 Apr 2026.